Early Adenoviral Gene Expression Mediates Immunosuppression by Transduced Dendritic Cell (DC): Implications for Immunotherapy Using Genetically Modified DC1

Long-lasting, high-level gene expression in the absence of a toxic or inflammatory response to viral Ags is necessary for the successful application of genetically modified dendritic cell (DC). We previously demonstrated that efficient transduction of mature DC using ΔE1ΔE3 adenoviruses suppressed their stimulatory capacity for T cells. The current study was designed to investigate in more detail the suppressive effect of Ad-DC. We demonstrate that immunosuppression is not mediated by alterations in the T cell phenotype or cytokine profiles released by stimulated T cells. Also DC phenotypes are not affected. However, we demonstrate a cell cycle arrest of the T cell population stimulated by adenovirally transduced DC. Surprisingly, only freshly transduced DC are perturbed in their stimulatory capacity. Experiments using cycloheximide to block early intracellular viral gene expression showed that viral genes expressed in DC are responsible for this transient immunosuppression. In agreement with these findings, high-capacity (gutless) Ad-vectors that differ in viral gene expression from conventional ΔE1ΔE3 adenovirus are suitable for an efficient transduction of human DC. DC transduced with gutless Ad-vectors showed a high allostimulatory capacity for CD4+ and CD8+ T cells. Thus, the immunosuppressive effect of ΔE1ΔE3 Ad-transduced mature DC seems to be the result of early viral gene expression in DC that can be prevented using gutless Ad-vectors for transduction. These results have important implications for the use of genetically modified DC for therapeutic application.

[1]  H. Nisenbaum,et al.  Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  M. Roth,et al.  Helper-Dependent Adenoviral Vectors Efficiently Express Transgenes in Human Dendritic Cells but Still Stimulate Antiviral Immune Responses1 , 2002, The Journal of Immunology.

[3]  S. Kochanek,et al.  A DNA-based method to assay total and infectious particle contents and helper virus contamination in high-capacity adenoviral vector preparations. , 2002, Human gene therapy.

[4]  A. Enk,et al.  A comparison of two types of dendritic cell as adjuvants for the induction of melanoma‐specific T‐cell responses in humans following intranodal injection , 2001, International journal of cancer.

[5]  S. Kochanek,et al.  Comparison of long-term transgene expression after non-viral and adenoviral gene transfer into primary articular chondrocytes , 2001, Histochemistry and Cell Biology.

[6]  J. Hauber,et al.  Mature Dendritic Cells Infected with Herpes Simplex Virus Type 1 Exhibit Inhibited T-Cell Stimulatory Capacity , 2000, Journal of Virology.

[7]  M. Eichelberger,et al.  Dose-Dependent Changes in Influenza Virus-Infected Dendritic Cells Result in Increased Allogeneic T-Cell Proliferation at Low, but Not High, Doses of Virus , 2000, Journal of Virology.

[8]  G. Linette,et al.  In Vitro Priming with Adenovirus/gp100 Antigen-Transduced Dendritic Cells Reveals the Epitope Specificity of HLA-A*0201-Restricted CD8+ T Cells in Patients with Melanoma1 , 2000, Journal of Immunology.

[9]  P. Vidalain,et al.  Measles Virus Induces Abnormal Differentiation of CD40 Ligand-Activated Human Dendritic Cells1 , 2000, The Journal of Immunology.

[10]  A. Enk,et al.  Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity , 2000, Gene Therapy.

[11]  R. Steinman,et al.  Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. , 1999, Journal of immunology.

[12]  A. Enk,et al.  Dendritic cell‐based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti‐melanoma immunity , 1999, The journal of gene medicine.

[13]  O. Majdic,et al.  Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10. , 1999, The Journal of clinical investigation.

[14]  R. Steinman,et al.  Recombinant adenovirus is an efficient and non‐perturbing genetic vector for human dendritic cells , 1999, European journal of immunology.

[15]  P. Seth,et al.  Recombinant, Replication-Defective Adenovirus Gene Transfer Vectors Induce Cell Cycle Dysregulation and Inappropriate Expression of Cyclin Proteins , 1998, Journal of Virology.

[16]  L. Butterfield,et al.  Generation of CD8+ and CD4+ T-cell response to dendritic cells genetically engineered to express the MART-1/Melan-A gene. , 1998, Cancer research.

[17]  A. Ribas,et al.  Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus. , 1998, Journal of immunology.

[18]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[19]  Dirk Schadendorf,et al.  Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells , 1998, Nature Medicine.

[20]  A. Enk,et al.  Pro‐inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum‐free conditions , 1997, European journal of immunology.

[21]  V. ter meulen,et al.  Cell cycle arrest rather than apoptosis is associated with measles virus contact-mediated immunosuppression in vitro. , 1997, The Journal of general virology.

[22]  S. Rafii,et al.  Dendritic Cells Genetically Modified with an Adenovirus Vector Encoding the cDNA for a Model Antigen Induce Protective and Therapeutic Antitumor Immunity , 1997, The Journal of experimental medicine.

[23]  S. Rosenberg,et al.  Dendritic Cells Retrovirally Transduced with a Model Antigen Gene Are Therapeutically Effective against Established Pulmonary Metastases , 1997, The Journal of experimental medicine.

[24]  R. Steinman,et al.  Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors , 1997, The Journal of experimental medicine.

[25]  D. Kufe,et al.  Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells , 1997, Gene Therapy.

[26]  M. Lotze,et al.  Genetically modified bone marrow‐derived dendritic cells expressing tumor‐associated viral or “self” antigens induce antitumor immunity in vivo , 1997, European journal of immunology.

[27]  J. Banchereau,et al.  Measles Virus Infects Human Dendritic Cells and Blocks Their Allostimulatory Properties for CD4+ T Cells , 1997, The Journal of experimental medicine.

[28]  C. Rabourdin-Combe,et al.  Measles Virus Suppresses Cell-mediated Immunity by Interfering with the Survival and Functions of Dendritic and T Cells , 1997, The Journal of experimental medicine.

[29]  F. Graham,et al.  Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination. , 1997, Human gene therapy.

[30]  M. Kitamura,et al.  Construction of adenovirus vectors through Cre-lox recombination , 1997, Journal of virology.

[31]  M. Billeter,et al.  Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. H. van der Burg,et al.  Peptide‐pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA‐A*0201‐binding peptides from the Melan‐A/MART‐1 self antigen , 1996, European journal of immunology.

[33]  M. Mohamadzadeh,et al.  Increased level of intracellular MHC class II molecules in murine Langerhans cells following in vivo and in vitro administration of contact allergens. , 1992, The Journal of investigative dermatology.

[34]  M. Oldstone,et al.  Measles virus inhibits mitogen-induced T cell proliferation but does not directly perturb the T cell activation process inside the cell. , 1992, Virology.

[35]  C. Nathan,et al.  Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. , 1988, Journal of immunology.

[36]  A. Altman,et al.  Suppression of T lymphocyte function by measles virus is due to cell cycle arrest in G1. , 1988, Journal of immunology.

[37]  R. Steinman,et al.  The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.